Gastroenterologie
a hepatologie

Doporučení Pracovní skupiny pro idiopatické střevní záněty pro dia­gnostiku Crohnovy choroby

Martin Bortlík¹, Dana Ďuricová², Pavel Drastich ^{Orcid.org  3}, Václav Mandys⁴, Zuzana Šerclová ^{Orcid.org  5}, Naděžda Machková², Aleš Novotný ^{Orcid.org  6}, Karel Mareš⁷, Jiří Stehlík ^{Orcid.org  8}, Milan Lukáš²

+ Affiliation
¹ Gastroenterologické oddělení, Nemocnice České Budějovice, a. s.
² Klinické a výzkumné centrum pro střevní záněty, Klinické centrum ISCARE a. s. a 1. LF UK v Praze
³ Klinika hepatogastroenterologie, Transplantcentrum, IKEM, Praha
⁴ Ústav patologie, 3. LF UK a FNKV, Praha
⁵ Chirurgické oddělení, NH Hospital a.s., Nemocnice Hořovice
⁶ IV. interní klinika – klinika gastroenterologie a hepatologie 1. LF UK a VFN v Praze
⁷ Oddělení gastroenterologie, Nemocnice Na Homolce, Praha
⁸ Gastroenterologické oddělení, Krajská zdravotní, a.s., Masarykova nemocnice v Ústí nad Labem, o.z.

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Literature

1. Baumgart DC, Sandborn WJ. Crohn‘s disease. Lancet 2012; 380(9853): 1590–1605. doi: 10.1016/ S0140-6736(12)60026-9.
2. Dušek L, Benešová K, Ngo O et al. Epidemiologie idiopatických střevních zánětů v české populaci – časový vývoj a statistické predikce počtu pacientů. Gastroent Hepatol 2019; 73(3): 257–264. doi: 10.14735/ amgh2019257.
3. Bortlík M, Ďuricová D, Novotný A et al. Doporučení Pracovní skupiny pro idiopatické střevní záněty pro dia­gnostiku a medikamentózní léčbu ulcerózní kolitidy. Gastroent Hepatol 2022; 76(1): 13–28. doi: 10.48095/ ccgh202213.
4. Atkins D, Best D, Briss PA et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328(7454): 1490. doi: 10.1136/ BMJ.328.7454.1490.
5. Feuerstein JD, Cheifetz AS. Crohn’s Disease: Epidemiology, Dia­gnosis, and Management. Mayo Clin Proc 2017; 92(7): 1088–1103. doi: 10.1016/ j.mayocp.2017.04.010.
6. Lewis JD, Rutgeerts P, Feagan BG et al. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn‘s Disease. Inflamm Bowel Dis 2020; 26(2): 304–313. doi: 10.1093/ ibd/ izz241.
7. Rogler G, Singh A, Kavanaugh A et al. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology 2021; 161(4): 1118–1132. doi: 10.1053/ j.gastro.2021.07.042.
8. Gordon H, Burisch J, Ellul P et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis 2024; 18(1): 1–37. doi: 10.1093/ ecco-jcc/ jjad108.
9. Ricciuto A, Mack DR, Huynh HQ et al. Dia­gnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn‘s Disease. J Crohns Colitis 2021; 15(3): 419–431. doi: 10.1093/ ecco-jcc/ jjaa197.
10. Cantoro L, Monterubbianesi R, Falasco G et al. The Earlier You Find, the Better You Treat: Red Flags for Early Dia­gnosis of Inflammatory Bowel Disease. Dia­gnostics (Basel) 2023; 13(20): 3183. doi: 10.3390/ dia­gnostics13203183.
11. Solem CA, Loftus EV Jr, Tremaine WJ et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11(8): 707–712. doi: 10.1097/ 01.mib.0000173271.18319.53.
12. von Roon AC, Karamountzos L, Purkayastha S et al. Dia­gnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007; 102(4): 803–813. doi: 10.1111/ j.1572-0241. 2007.01126.x.
13. Gold SL, Rabinowitz LG, Manning L et al. High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course. Inflamm Bowel Dis 2023; 29(3): 423–429. doi: 10.1093/ ibd/ izac102.
14. Peeters M, Joossens S, Vermeire S et al. Dia­gnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Autoantibodies in Inflammatory Bowel Disease. Am J Gastroenterol 2001; 96(3): 730–734. doi: 10.1111/ j.1572-0241.2001.03613.x.
15. Forcione DG, Rosen MJ, Kisiel JB et al. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn’s disease Gut 2004; 53(8): 1117–1122. doi: 10.1136/ gut.2003.030734.
16. Costa Santos MP, Gomes C, Torres J. Familial and ethnic risk in inflammatory bowel disease. Ann Gastroenterol 2018; 31(1): 14–23. doi: 10.20524/ aog.2017.0208.
17. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007; 13(46): 6134–6139. doi: 10.3748/ wjg.v13.i46.6134.
18. Lukáš M et al. Pokroky v dia­gnostice a léčbě idiopatických střevních zánětů. Praha: Galén 2019.
19. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postopoerative course of Crohn’s disease. Gastroenterology 1990; 99(4): 956–963. doi: 10.1016/ 0016-5085(90)90613-6.
20. Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn’s disease. Am J Surg Pathol 1998; 22(4): 383–390. doi: 10.1097/  00000478-199804000-00001.
21. Takenaka K, Ohtsuka K, Kitazume Y et al. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn‘s disease. Gastroenterology 2014; 147(2): 334–342. doi: 10.1053/  j.gastro.2014.04.008.
22. Lang-Schwarz C, Agaimy A, Atreya R et al. Maximizing the dia­gnostic information from bio­psies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn‘s disease. Virchows Arch 2021; 478(3): 581–594. doi: 10.1007/ s00428-020-02982-7.
23. Magro F, Langner C, Driessen A et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013; 7(10): 827–851. doi: 10.1016/ j.crohns.2013.06.001.
24. Rezazadeh Ardabili A, Goudkade D, Wintjens D et al. Histopathological Features in Colonic Biopsies at Dia­gnosis Predict Long-term Disease Course in Patients with Crohn‘s Disease. J Crohns Colitis 2021; 15(11): 1885–1897. doi: 10.1093/ ecco-jcc/ jjab087.
25. Magro F, Sabino J, Rosini F et al. ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology. J Crohn Colitis 2022; 16(6): 876–883. doi: 10.1093/ ecco-jcc/ jjac006.
26. Negaard A, Paulsen V, Sandvik L et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn‘s disease, the oral contrast method and MR enteroclysis. Eur Radiol 2007; 17(9): 2294–2301. doi: 10.1007/ s00330-007-0648-4.
27. Wold PB, Fletcher JG, Johnson CD et al. Assessment of small bowel Crohn’s disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy – feasibility study. Radiology 2003; 229(1): 275–281. doi: 10.1148/ radiol.2291020877.
28. Gomollón F, Dignass A, Annese V et al. 3rd European Evidence-based Consensus on the Dia­gnosis and Management of Crohn‘s Disease 2016: Part 1: Dia­gnosis and Medical Management. J Crohns Colitis 2017; 11(1): 3–25. doi: 10.1093/ ecco-jcc/ jjw168.
29. Bruining DH, Zimmermann EM, Loftus EV Jr et al. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn‘s Disease. Radiology 2018; 286(3): 776–799. doi: 10.1148/ radiol.2018171737.
30. Panés J, Bouzas R, Chaparro M et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the dia­gnosis, assessment of activity and abdominal complications of Crohn‘s disease. Aliment Pharmacol Ther 2011; 34(2): 125–145. doi: 10.1111/ j.1365-2036.2011.047 10.x.
31. Calabrese E, Maaser C, Zorzi F et al. Bowel Ultrasonography in the Management of Crohn‘s Disease. A Review with Recommendations of an International Panel of Experts. Inflamm Bowel Dis 2016; 22(5): 1168–1183. doi: 10.1097/ MIB.0000000000000706.
32. Maaser C, Sturm A, Vavricka SR et al. ECCO-ESGAR Guideline for Dia­gnostic Assessment in IBD Part 1: Initial dia­gnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019; 13(2): 144–164. doi: 10.1093/ ecco- jcc/ jjy113.
33. Pallotta N, Vincoli G, Montesani C et al. Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn‘s disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis 2012; 18(1): 74–84. doi: 10.1002/ ibd.21678.
34. Gralnek IM, Defranchis R, Seidman E et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27(2): 146–154. doi: 10.1111/ j.1365-2036.2007.03556.x.
35. Panes J, Rimola J. Perianal fistulizing Crohn’s disease: pathogenesis, dia­gnosis and therapy. Nat Rev Gastroenterol Hepatol 2017; 14(11): 652–664. doi: 10.1038/ nrgastro.2017.104.
36. Zhao M, Sheng Lo BZ, Vester-Andersen MK et al. A 10 years follow-up study of the natural history of perianal Crohn’s disease in a danish population – based inception cohort. Inflamm Bowel Dis 2019; 25(7): 1227–1236. doi: 10.1093/ IBD/ izy374.
37. Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976; 63(1): 1–12. doi: 10.1002/ bjs.1800630102.
38. Sandborn WJ, Fazio VW, Feagan BG et al; American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn’s disease. Gastroenterology 2003; 125(5), 1508–1530. doi: 10.1016/  j.gastro.2003.08.025.
39. Buchanan GN, Halligan S, Bartram CI et al. Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard. Radiology 2004; 233(3): 674–681. doi: 10.1148/ radiol.2333031724.
40. Šerclová Z, Ryska O, Bortlík M et al. Doporučené postupy chirurgické léčby pacientů s idiopatickými střevními záněty – 2. část: Crohnova nemoc. Gastroent Hepatol 2015; 69(3): 223–238. doi: 10.14735/ amgh2015223.
41. Schoepfer AM, Dehlavi MA, Fournier N et al. Dia­gnostic delay in Crohn‘s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol 2013; 108(11): 1744–1753. doi: 10.1038/ ajg.2013.248.